Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and...

42
ResMed February 2007 Global leaders in sleep and respiratory medicine Entrepreneurship and Innovation Dr Peter C Farrell AM Chairman & CEO ResMed

Transcript of Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and...

Page 1: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

ResMed February 2007 Global leaders in sleep and respiratory medicine

Entrepreneurship and

Innovation

Dr Peter C Farrell AM

Chairman & CEO ResMed

Page 2: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

2 ResMed February 2007 Global leaders in sleep and respiratory medicine

Innovation & Entrepreneurship

“It is the mark of the instructed mind to remain satisfied with the degree of precision which the nature of the subject permits and not seek an exactness where only an approximation of the truth is possible.”

Aristotle (384-322 BC)

“It is the mark of the instructed mind to remain satisfied with the degree of precision which the nature of the subject permits and not seek an exactness where only an approximation of the truth is possible.”

Aristotle (384-322 BC)

Page 3: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

3 ResMed February 2007 Global leaders in sleep and respiratory medicine

Shifts economic resources out of an area of lower, into an area of higher productivity and greater yield

Jean-Baptiste Say 1776-1832

• Entrepreneurs create value

• Entrepreneurs are not risk takers, they are opportunity seekers

The Entrepreneur

Page 4: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

4 ResMed February 2007 Global leaders in sleep and respiratory medicine

Innovation .I.

Almost right

• Creativity is thinking up new things. INNOVATION is doing new things

Theodore Levitt/HBS

Right*

• INNOVATION is the process of turning ideas into manufacturable and marketable form

Watts Humphrey/Author

Almost right

• Creativity is thinking up new things. INNOVATION is doing new things

Theodore Levitt/HBS

Right*

• INNOVATION is the process of turning ideas into manufacturable and marketable form

Watts Humphrey/Author

* The ultimate test for an innovation is that somebody writes a cheque

Page 5: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

5 ResMed February 2007 Global leaders in sleep and respiratory medicine

Innovation .II.

TECHNOLOGY has been and always will be the turbocharger of economic growth

And if INNOVATION is the key to wealth creation, then TECHNOLOGY is the enabler or the means

Robert Solow (1924- ) of MIT, won the Nobel Prize (1987) showing that technology was the key driver of US economic growth over and above traditional economic inputs

TECHNOLOGY has been and always will be the turbocharger of economic growth

And if INNOVATION is the key to wealth creation, then TECHNOLOGY is the enabler or the means

Robert Solow (1924- ) of MIT, won the Nobel Prize (1987) showing that technology was the key driver of US economic growth over and above traditional economic inputs

Page 6: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

6 ResMed February 2007 Global leaders in sleep and respiratory medicine

Innovation .III.

If we apply TECHNOLOGY to what we already do, it is called PRODUCTIVITY

If we apply TECHNOLOGY to something completely new, and it is successfully marketed, it is called INNOVATION

If we apply TECHNOLOGY to what we already do, it is called PRODUCTIVITY

If we apply TECHNOLOGY to something completely new, and it is successfully marketed, it is called INNOVATION

Page 7: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

7 ResMed February 2007 Global leaders in sleep and respiratory medicine

WORKS ☺

A DOG WORKS

BIG

Opportunity ($)

MODERATE

LATE EARLYTiming

Opportunity Selection

Andy Grove, INTEL

Page 8: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

8 ResMed February 2007 Global leaders in sleep and respiratory medicine

Where Do We Put Our Scarce Resources? .I.

A selection template

• MARKET ASSESSMENT: Is it sufficiently big and accessible?

• PEOPLE: Do we have access to world-class people?

• FINANCE: Can we really see a path to the financial resources needed for project completion?

A selection template

• MARKET ASSESSMENT: Is it sufficiently big and accessible?

• PEOPLE: Do we have access to world-class people?

• FINANCE: Can we really see a path to the financial resources needed for project completion?

Page 9: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

9 ResMed February 2007 Global leaders in sleep and respiratory medicine

Where Do We Put Scarce Resources? .II.

• TIMING: Will it happen in our lifetime? (The 4/2 rule)

• TECHNOLOGY ASSESSMENT: What does the competition know now and how could the competitive terrain change?

• ALPHA FACTOR: Do we really love it?

• Then do the FINANCIAL ANALYSIS(Break-even, ROI, NPV, EVA, Monte Carlo, etc) to make a final selection

• The INNOVATION needs to be exciting and intriguing but it also has to pay the rent

• TIMING: Will it happen in our lifetime? (The 4/2 rule)

• TECHNOLOGY ASSESSMENT: What does the competition know now and how could the competitive terrain change?

• ALPHA FACTOR: Do we really love it?

• Then do the FINANCIAL ANALYSIS(Break-even, ROI, NPV, EVA, Monte Carlo, etc) to make a final selection

• The INNOVATION needs to be exciting and intriguing but it also has to pay the rent

Page 10: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

10 ResMed February 2007 Global leaders in sleep and respiratory medicine

If I were to have only 3 things to measure in a business they would be:

– Customer satisfaction

– Employee satisfaction and

– Cash flowDr Jack Welch

Former CEO, General Electric

If I were to have only 3 things to measure in a business they would be:

– Customer satisfaction

– Employee satisfaction and

– Cash flowDr Jack Welch

Former CEO, General Electric

Base Fundamentals

Page 11: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

11 ResMed February 2007 Global leaders in sleep and respiratory medicine

To become the global leader in development, manufacture, and marketing of innovative products for the diagnosis, treatment, and

management of sleep-disordered breathing

ResMed’s Mission

Page 12: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

12 ResMed February 2007 Global leaders in sleep and respiratory medicine

A Case Study: ResMed (NYSE: RMD)

Page 13: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

13 ResMed February 2007 Global leaders in sleep and respiratory medicine

Company Overview .I.

• MBO from Baxter Healthcare in 1989

• The leading technological innovator in ~$2B global SDB market

• Presence in over 100 countries; HQ in San Diego with direct offices in Sydney, Oxford, Munich, Basel, Lyon, Helsinki, Tokyo, Delhi, Gothenburg, Singapore, & Auckland

• Robust financial performance: 47 consecutive record quarters

• ResMed is listed on both the NYSE (RMD) and the ASX (RMD) and market cap is about USD 4 billion (February 2007)

• Ten year CAGR: ~ 35% for revenues / ~40% for net income

• Strong, experienced management team (~ 3000)

• MBO from Baxter Healthcare in 1989

• The leading technological innovator in ~$2B global SDB market

• Presence in over 100 countries; HQ in San Diego with direct offices in Sydney, Oxford, Munich, Basel, Lyon, Helsinki, Tokyo, Delhi, Gothenburg, Singapore, & Auckland

• Robust financial performance: 47 consecutive record quarters

• ResMed is listed on both the NYSE (RMD) and the ASX (RMD) and market cap is about USD 4 billion (February 2007)

• Ten year CAGR: ~ 35% for revenues / ~40% for net income

• Strong, experienced management team (~ 3000)

Page 14: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

14 ResMed February 2007 Global leaders in sleep and respiratory medicine

Company Overview .II.

• 54% of revenues are generated in the Americas; Germany is 16%; France is 10%, Japan is ~ 3% (>80% of business in 4 countries)

• ResMed has either the #1 or the #2 market position in all major markets

• ResMed has made the Forbes 200 Best Small Companies in America for 10 consecutive years (1997-2006) #86 in 2006

• 54% of revenues are generated in the Americas; Germany is 16%; France is 10%, Japan is ~ 3% (>80% of business in 4 countries)

• ResMed has either the #1 or the #2 market position in all major markets

• ResMed has made the Forbes 200 Best Small Companies in America for 10 consecutive years (1997-2006) #86 in 2006

Page 15: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

15 ResMed February 2007 Global leaders in sleep and respiratory medicine

Strong Financial PerformanceQuarterly

0

20

40

60

80

100

120

140

160

180

Q4,

95

Q2,

96

Q4,

96

Q2,

97

Q4,

97

Q2,

98

Q4,

98

Q2,

99

Q4,

99

Q2,

00

Q4,

00

Q2,

01

Q4,

01

Q2,

02

Q4,

02

Q2,

03

Q4,

03

Q2,

04

Q4,

04

Q2,

05

Q4,

05

Q2,

06

Q4,

06

Q2,

07

0

20

40

60

80

100

120

140

160

180

Q4,

95

Q2,

96

Q4,

96

Q2,

97

Q4,

97

Q2,

98

Q4,

98

Q2,

99

Q4,

99

Q2,

00

Q4,

00

Q2,

01

Q4,

01

Q2,

02

Q4,

02

Q2,

03

Q4,

03

Q2,

04

Q4,

04

Q2,

05

Q4,

05

Q2,

06

Q4,

06

Q2,

07

US$ (Million)

Trailing 12 Months:USD676M Revenues USD124M Net Income*

Quarterly Net Revenues to Q2 FY’07

* Excluding stock-based compensation, restructuring, AJCA repatriation tax, acquisition-related costs and acquired intangible assets

Page 16: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

16 ResMed February 2007 Global leaders in sleep and respiratory medicine

• “Among specific sleep disorders, the most serious in terms of morbidity and mortality is obstructive sleep apnea.”

• “... it is time for the nation to wake up to the staggering impact of sleep disturbances on the health and welfare of our society, an impact that rivals that of smoking.”

SLEEP APNEA – A MAJOR PUBLIC HEALTH PROBLEM

EDITORIAL

Over a Decade Ago!

Page 17: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

17 ResMed February 2007 Global leaders in sleep and respiratory medicine

Signs/Symptoms of SDB/OSA

• Hypertension (JNC7)

• Heart arrhythmias (AF)

• Morning headaches

• Depression

• Nocturia

• Reflux (GERD)

• Impotence

• Accelerated ageing/growth depression (Children)

• Impaired glucose metabolism – pre diabetes

• Cognitive dysfunction

• Excessive daytime sleepiness

• Hypertension (JNC7)

• Heart arrhythmias (AF)

• Morning headaches

• Depression

• Nocturia

• Reflux (GERD)

• Impotence

• Accelerated ageing/growth depression (Children)

• Impaired glucose metabolism – pre diabetes

• Cognitive dysfunction

• Excessive daytime sleepiness

Page 18: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

18 ResMed February 2007 Global leaders in sleep and respiratory medicine

I want to die like my grandfather did - peacefully in his sleep,

not screaming like the other passengers in his car…

I want to die like my grandfather did - peacefully in his sleep,

not screaming like the other passengers in his car…

Consequences of Untreated SDB/OSA

Page 19: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

19 ResMed February 2007 Global leaders in sleep and respiratory medicine

Sleep Disordered Breathing (SDB)

• Prevalent in 20 to 30% of adults – ~7% have SDB at highly significant clinical levels, primarily OSA

• Hypertension (40-50% with SDB)• Diabetes (~ 70% with SDB)• Anesthesiology (PCA)• Congestive Heart Failure (~ 70% with SDB)• Other: Stroke/TIA (~70% with SDB); COPD

(~ 30%; hypercapnic hypoventilation)• Missed diagnosis is sadly quite common by PCPs and all

medical specialists

• Prevalent in 20 to 30% of adults – ~7% have SDB at highly significant clinical levels, primarily OSA

• Hypertension (40-50% with SDB)• Diabetes (~ 70% with SDB)• Anesthesiology (PCA)• Congestive Heart Failure (~ 70% with SDB)• Other: Stroke/TIA (~70% with SDB); COPD

(~ 30%; hypercapnic hypoventilation)• Missed diagnosis is sadly quite common by PCPs and all

medical specialists

Page 20: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

20 ResMed February 2007 Global leaders in sleep and respiratory medicine

Page 21: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

21 ResMed February 2007 Global leaders in sleep and respiratory medicine

Summary .I.

• SDB/OSA is a major public health problem on a level equivalent to that of tobacco smoking (NEJM April 1993)

• SDB/OSA is the major cause of hypertension which, in turn, is the major cause of heart disease and stroke, the #1 and #3 killers in most western countries

• SDB/OSA is easy to diagnose and easy to treat; it has been shockingly neglected by the medical establishment

Page 22: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

22 ResMed February 2007 Global leaders in sleep and respiratory medicine

Summary .II.

• ResMed’s biggest competitor is ignorance.

• ResMed is the leading global technology company in the SDB/OSA space; we have the track record to prove it.

• The SDB/OSA opportunity is a marathon and we are only lacing our shoes; it is time for the nation and the world to wake up to sleep

Page 23: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed
Page 24: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

24 ResMed February 2007 Global leaders in sleep and respiratory medicine

RESMEDRESMEDIt’s Time to Wake Up

to SleepIt’s Time to Wake Up

to Sleep

Page 25: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

25 ResMed February 2007 Global leaders in sleep and respiratory medicine

“The fault dear Brutus lies not in our stars but in ourselves.”

Julius Caesar

“The fault dear Brutus lies not in our stars but in ourselves.”

Julius Caesar

Innovation & Entrepreneurship

Page 26: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

26 ResMed February 2007 Global leaders in sleep and respiratory medicine

Strengths .I.

• Australia has had solid economic performance over the past decade

• There is minimal corruption

• There is a well-educated workforce

• There is an established research base and infrastructure, particularly in medicine

• Australia has had solid economic performance over the past decade

• There is minimal corruption

• There is a well-educated workforce

• There is an established research base and infrastructure, particularly in medicine

Page 27: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

27 ResMed February 2007 Global leaders in sleep and respiratory medicine

Strengths .II.

• An understanding of globalization

• Some born-global companies e.g. ResMed and Cochlear

• A “knowledge-economy” awareness

• Capital accumulation through super funds

• A democratic and open society

• An understanding of globalization

• Some born-global companies e.g. ResMed and Cochlear

• A “knowledge-economy” awareness

• Capital accumulation through super funds

• A democratic and open society

Page 28: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

28 ResMed February 2007 Global leaders in sleep and respiratory medicine

Weaknesses .I.

• Too few engineers/technologists being produced

• Too much regulation

• A socialized approach to the world – we need to focus more on equal opportunities then equal outcomes.

• Heavy trade union influence but still reducing in clout

• Geographic isolation

• High transportation costs

• Too few engineers/technologists being produced

• Too much regulation

• A socialized approach to the world – we need to focus more on equal opportunities then equal outcomes.

• Heavy trade union influence but still reducing in clout

• Geographic isolation

• High transportation costs

Page 29: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

29 ResMed February 2007 Global leaders in sleep and respiratory medicine

Weaknesses .II.

• Woefully bureaucratic secondary and tertiary education systems

• Insufficient management depth

• Poor developer of technology; we are more users than developers

• A serious economic imbalance exists between imports (ETMs) and exports (resources)

• Under-investment in infrastructure

• Lack of clarity in State/Federal responsibilities; very muddied waters

• An excessively complex and unintelligible tax regime

• Woefully bureaucratic secondary and tertiary education systems

• Insufficient management depth

• Poor developer of technology; we are more users than developers

• A serious economic imbalance exists between imports (ETMs) and exports (resources)

• Under-investment in infrastructure

• Lack of clarity in State/Federal responsibilities; very muddied waters

• An excessively complex and unintelligible tax regime

Page 30: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

30 ResMed February 2007 Global leaders in sleep and respiratory medicine

Opportunities .I.

• Our near-term opportunities involve tax reform, workplace relations, and revamping the bureaucracy

• Reducing red tape

• Reforming State taxes (Payroll tax?)

• Providing greater R&D incentives, up to 200% deduction for bona fide R&D expenditures

• Freeing up super funds to invest on a voluntary basis, in high risk/high return activities; up to 5% should be freed up.

• Our near-term opportunities involve tax reform, workplace relations, and revamping the bureaucracy

• Reducing red tape

• Reforming State taxes (Payroll tax?)

• Providing greater R&D incentives, up to 200% deduction for bona fide R&D expenditures

• Freeing up super funds to invest on a voluntary basis, in high risk/high return activities; up to 5% should be freed up.

Page 31: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

31 ResMed February 2007 Global leaders in sleep and respiratory medicine

Opportunities .II.

• Better academic, government and industry co-operation

• Some infrastructure exists: expertise in manufacturing, legal and accounting exists at needed levels

• Relatively low cost environment

• Australia is taken seriously – Nobel prizes; economic performance; reliable ally, etc.

• Need to privatize more Government businesses

• Reform of our tertiary system is a sine qua non; let’s remove the shackles from our Universities

• Better academic, government and industry co-operation

• Some infrastructure exists: expertise in manufacturing, legal and accounting exists at needed levels

• Relatively low cost environment

• Australia is taken seriously – Nobel prizes; economic performance; reliable ally, etc.

• Need to privatize more Government businesses

• Reform of our tertiary system is a sine qua non; let’s remove the shackles from our Universities

Page 32: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

32 ResMed February 2007 Global leaders in sleep and respiratory medicine

Threats .I.

• Change-resistant

• Failure to execute

• Poor choice of opportunities for investment

• Lack of commitment to examining the future

• The need to punch above our weight

• Change-resistant

• Failure to execute

• Poor choice of opportunities for investment

• Lack of commitment to examining the future

• The need to punch above our weight

Page 33: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

33 ResMed February 2007 Global leaders in sleep and respiratory medicine

Threats .II.

• Stubbornness in the face of reality

• Lack of a sense of urgency

• Complacency on reform at all levels

• Stubbornness in the face of reality

• Lack of a sense of urgency

• Complacency on reform at all levels

Page 34: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

34 ResMed February 2007 Global leaders in sleep and respiratory medicine

“Civilizations die from suicide not murder.”

Arnold Toynbee

“Civilizations die from suicide not murder.”

Arnold Toynbee

Innovation & Entrepreneurship

Page 35: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

35 ResMed February 2007 Global leaders in sleep and respiratory medicine

Innovation & Entrepreneurship

• The best universities in the world are in the US. They are either private (Stanford, MIT, Harvard, etc.) or research-based with relative autonomy (Berkeley, UCSD, UCLA, Washington, etc.)

• We need to be picking the low-hanging fruit for technology transfer

• The time to reform the tertiary sector is now.

• The best universities in the world are in the US. They are either private (Stanford, MIT, Harvard, etc.) or research-based with relative autonomy (Berkeley, UCSD, UCLA, Washington, etc.)

• We need to be picking the low-hanging fruit for technology transfer

• The time to reform the tertiary sector is now.

Page 36: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

36 ResMed February 2007 Global leaders in sleep and respiratory medicine

Innovation & Entrepreneurship

“Unless our “world-class” universities regain freedom to manage their own finances, decide their own pay scales and charge their own fees, there is no chance that they will maintain their international standing. Universities have to differentiate themselves or, in the long run, perish. If businesses were run like UK universities (or Australian ones) they would be bankrupt. Any business analyst would start by looking at demand, at the balance between future demand and supply in both vocational and non-vocational studies. And why pay for degrees with no cachet?”

Lord Rees-Mogg, Times of London (18/12/2002)

“Unless our “world-class” universities regain freedom to manage their own finances, decide their own pay scales and charge their own fees, there is no chance that they will maintain their international standing. Universities have to differentiate themselves or, in the long run, perish. If businesses were run like UK universities (or Australian ones) they would be bankrupt. Any business analyst would start by looking at demand, at the balance between future demand and supply in both vocational and non-vocational studies. And why pay for degrees with no cachet?”

Lord Rees-Mogg, Times of London (18/12/2002)

Page 37: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

37 ResMed February 2007 Global leaders in sleep and respiratory medicine

Innovation & Entrepreneurship

• Australia is way down the totem pole on GERD as % of GDP (1.6%) vs. Sweden (4.3%); Finland (3.5%); Japan (3.2%); Korea (2.9%); US (2.7%) etc.

• There is a gross imbalance between exports (resources) and imports (ETMs).

• We are not investing our windfall profits (exports to China and Japan) in our future.

• Australia is way down the totem pole on GERD as % of GDP (1.6%) vs. Sweden (4.3%); Finland (3.5%); Japan (3.2%); Korea (2.9%); US (2.7%) etc.

• There is a gross imbalance between exports (resources) and imports (ETMs).

• We are not investing our windfall profits (exports to China and Japan) in our future.

Page 38: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

38 ResMed February 2007 Global leaders in sleep and respiratory medicine

Innovation & Entrepreneurship

“It is true that by blundering about we stumbled upon gold, but the fact remains that we were searching for gold.”

Sir Francis Crick/Double Helix

“It is true that by blundering about we stumbled upon gold, but the fact remains that we were searching for gold.”

Sir Francis Crick/Double Helix

Page 39: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

39 ResMed February 2007 Global leaders in sleep and respiratory medicine

Innovation & Entrepreneurship

What are the key elements of a tertiary education?

1. Expand the powers of the mind;

2. Advance learning;

3. Teach people that background of culture and social awareness upon which a healthy society depends; and finally

4. Teach people how to earn a living.

Lord Robbins (Quote in a letter to the London Times)

What are the key elements of a tertiary education?

1. Expand the powers of the mind;

2. Advance learning;

3. Teach people that background of culture and social awareness upon which a healthy society depends; and finally

4. Teach people how to earn a living.

Lord Robbins (Quote in a letter to the London Times)

Page 40: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

40 ResMed February 2007 Global leaders in sleep and respiratory medicine

Innovation & Entrepreneurship

“The best qualification for innovation is a basic training in engineering. Engineers are taught that design matters; that most things are part of a system in which everything interacts: that their job is to worry about trade-offs and that they must continually be measuring the robustness of the systems they set up. Such a frame of mind fosters innovation. Many of the greatest corporate leaders in America, Europe and Japan, past and present, trained first as engineers.”

Dr. Michael Hammer, Author/Former MIT Professor

“The best qualification for innovation is a basic training in engineering. Engineers are taught that design matters; that most things are part of a system in which everything interacts: that their job is to worry about trade-offs and that they must continually be measuring the robustness of the systems they set up. Such a frame of mind fosters innovation. Many of the greatest corporate leaders in America, Europe and Japan, past and present, trained first as engineers.”

Dr. Michael Hammer, Author/Former MIT Professor

Page 41: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

41 ResMed February 2007 Global leaders in sleep and respiratory medicine

Conclusions .I.

• The Australian economy in good shape but future far from sanguine.

• Work choice is fundamental to productivity and workplace flexibility

• Tax reform is a sine qua non: personal taxes need to reflect corporate tax; and increased R&D incentives are needed.

• The current welfare system, with the churning which takes place, is ludicrous. It is expensive and inefficient (Dr. Peter Saunders, CIS).

• The Australian economy in good shape but future far from sanguine.

• Work choice is fundamental to productivity and workplace flexibility

• Tax reform is a sine qua non: personal taxes need to reflect corporate tax; and increased R&D incentives are needed.

• The current welfare system, with the churning which takes place, is ludicrous. It is expensive and inefficient (Dr. Peter Saunders, CIS).

Page 42: Entrepreneurship and Innovation - CEDA · 2 ResMed February 2007 Global leaders in sleep and respiratory medicine Innovation & Entrepreneurship “It is the mark of the instructed

42 ResMed February 2007 Global leaders in sleep and respiratory medicine

Conclusions .II.

• Universities need to be unshackled; they should compete for students and endowments, charge what they like and pay above market rates for talent.

• Universities should be allowed to govern themselves without interference from bureaucrats or politicians, in the same view as Stanford and MIT.

• Up to 5% of super funds should be voluntarily invested in high risk, high return entities. The current modus operandi of the Super Funds is woefully inadequate, leaves money on the table and prevents the economy growing and becoming less dependent upon resources.

• Universities need to be unshackled; they should compete for students and endowments, charge what they like and pay above market rates for talent.

• Universities should be allowed to govern themselves without interference from bureaucrats or politicians, in the same view as Stanford and MIT.

• Up to 5% of super funds should be voluntarily invested in high risk, high return entities. The current modus operandi of the Super Funds is woefully inadequate, leaves money on the table and prevents the economy growing and becoming less dependent upon resources.